tetrandrine has been researched along with Extramembranous Glomerulopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, J; Wei, X; Yin, J; Yu, J; Zhu, B; Zhu, C | 1 |
1 other study(ies) available for tetrandrine and Extramembranous Glomerulopathy
| Article | Year |
|---|---|
Tetrandrine may treat membranous glomerulopathy via P13K/Akt signaling pathway regulation: therapeutic mechanism validation using Heymann nephritis rat model.
Topics: Animals; Antioxidants; Benzylisoquinolines; Disease Models, Animal; Glomerulonephritis, Membranous; Male; Network Pharmacology; Phosphatidylinositol 3-Kinases; Protein Interaction Maps; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction | 2021 |